[Low doses of quetiapine (Seroquel) as an impulsivity corrector in patients with bipolar affective disorder in remission].

M A Morozova,S S Potanin,D S Burminskiy,A G Beniashvili,G E Rupchev,T A Lepilkina,M Yu Sorokin,E D Kasyanov,G E Mazo,D A Tarumov,A G Trufanov,K V Markin,T Z Beybalaeva,A A Katok, D S Tsapko

Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova（2022）

引用 1|浏览4

暂无评分

摘要

The results of the study showed that add-on of the low doses of quetiapine (Seroquel) significantly decreases impaired impulse control in remitted patients with bipolar affective disorders both in self-evaluation and in risk-taking experimental test. The drop of high level of impulsivity can improve the quality and stability of remission and reduce behavioral risks due to impaired impulse control.

查看译文

关键词

Balloon risk test,Barratt scale,Go-No-Go test,Seroquel,bipolar affective disorder,impulsivity,quetiapine

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要